ABSTRACT
PURPOSE: To study the effects of a perindopril-based regimen on cardiovascular (CV) outcomes in patients with vascular disease in relation to background statin therapy. METHODS: A pooled analysis of the randomized ADVANCE, EUROPA, and PROGRESS trials was performed to evaluate CV outcomes in 29,463 patients with vascular disease treated with perindopril-based regimens versus placebo. The primary endpoint was a composite of CV mortality, nonfatal myocardial infarction, and stroke. Multivariable Cox regression analyses were performed to assess the effects of a perindopril-based regimen versus placebo in relation to statin use. RESULTS: At randomization, 39.5% of the overall combined study population used statins. After a mean follow-up of 4.0 years (SD 1.0), the cumulative event-free survival was highest in the statin/perindopril group and lowest in the no statin/placebo group (91.2% vs. 85.6%, respectively, log-rank p < 0.001). In statin users (adjusted hazard ratio [aHR] 0.87, 95% confidence interval [CI] 0.77-0.98) and non-statin users (aHR 0.80, 95% CI 0.74-0.87), a perindopril-based regimen was associated with a significantly lower risk of the primary endpoint when compared to placebo. The additional treatment effect appeared numerically greater in non-statin users, but the observed difference was statistically nonsignificant. CONCLUSION: Our data suggest that the treatment benefits of a perindopril-based regimen in patients with vascular disease are independent of statin use.
ABSTRACT
Considering the relevance of meat discoloration for meat production chain and the conflicting results regarding the influence of feeding regimes on color of fresh beef and the lack of meta-analytic studies on this subject we investigated the effect of grain-fed and pasture-fed regimes on color of beef longissimus from Bos cattle through a systematic review with meta-analysis. A systematic search from 2001 to 2021 was performed in two databases and 126 papers were eligible for meta-analysis. Pasture-fed longissimus beef exhibited higher a* (8.21%) and C* (8.61%) values, and lower h* values (17.18%) than grain-fed counterparts, indicating a greater color for longissimus beef from pasture-fed animals. Among the pasture-fed regimes, those containing alfalfa, bermudagrass, cowpea and pearl millet were the most effective for color improvements. Our findings indicate potential feeding regimes to mitigate global economic losses from meat discoloration and suggest the necessity to develop suitable processing strategies to improve the color of beef from grain-fed Bos cattle.
Subject(s)
Animal Feed , Meat , Muscle, Skeletal , Animal Feed/statistics & numerical data , Animals , Cattle , Color , Edible Grain , Meat/analysisABSTRACT
Canine mammary tumours represent a hard-prognostic task for veterinary clinicians. TNM staging and grading systems refer to a single tumour. Significant limits come to light when these systems are applied to multiple mammary tumours due to the arbitrary criterion in determining which single tumour is representative of the patient's prognosis. This study explored some clinical features of 50 dogs affected by at least one malignant mammary tumour. Clinical features and staging, together with histological classification and grading, have been related to disease-free survival (DFS) with the purpose to evaluate their impact on prognosis. The prognosis was worse in 10-11-year-old dogs (P < 0.05), in dogs affected by complex carcinoma (P < 0.05), and in patients assigned to Peña grade I (P < 0.05). The bodyweight was not linearly related to DFS (P < 0.01), and patients with a low number of neoformations (n ≤ 2) showed a better prognosis than dogs with 3-5 tumours (P < 0.05). Both the average and the total size of malignant tumours were related to DFS (P < 0.05). Dogs assigned with stage I had the best DFS (P < 0.05). In conclusion, the Peña grade I alone would not seem to guarantee a favourable prognosis when applied to mammary tumours in dogs affected by multiple simultaneous presentations. Different characteristics, besides tumour grading, such as tumour immunophenotype and expression of hormonal receptors, could in the future, contribute to elucidate the clinical behaviour of multiple canine mammary tumours.
Subject(s)
Carcinoma/veterinary , Dog Diseases/diagnosis , Mammary Neoplasms, Animal/diagnosis , Animals , Carcinoma/diagnosis , Dogs , Female , Neoplasm Grading/veterinary , Neoplasm Staging/veterinary , Retrospective StudiesABSTRACT
Non-ST-segment elevation acute coronary syndromes (NSTE-ACSs) are a group of clinical conditions characterized by acute myocardial ischemia. Conventional echocardiography is generally used to evaluate cardiac function using wall motion analysis and left ventricular ejection fraction but may be insufficient to explore all the complex features of NSTE-ACSs, which may vary substantially from patient to patient in terms of severity of ischemia and extent of involved myocardium. In the last years, speckle tracking echocardiography (STE) has become a widely available technique for the non-invasive assessment of cardiac function and has been repeatedly applied in the setting of NSTE-ACSs. In this review we summarize current evidence about the use of STE in patients with NSTE-ACSs, trying to underline advantages and limitations in comparison with conventional echocardiography for: diagnosis of NSTE-ACS, differential diagnosis, identification of high-risk patients, and prediction of outcome.
Subject(s)
Acute Coronary Syndrome , Acute Coronary Syndrome/diagnostic imaging , Echocardiography , Humans , Stroke Volume , Ventricular Function, LeftSubject(s)
Betacoronavirus , Cardiology/organization & administration , Cardiovascular Diseases/therapy , Cardiovascular Diseases/virology , Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Pneumonia, Viral/complications , Pneumonia, Viral/epidemiology , COVID-19 , Cardiovascular Diseases/diagnosis , Coronavirus Infections/prevention & control , Humans , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , SARS-CoV-2Subject(s)
Cardiovascular Diseases , Coronavirus , Betacoronavirus , COVID-19 , China , Coronavirus Infections , Humans , Pandemics , Pneumonia, Viral , SARS-CoV-2ABSTRACT
Local recurrence (LR) is the major concern in the treatment of feline injection-site sarcoma (FISS). Pretreatment leukocyte counts and ratios have been reported as diagnostic and/or prognostic markers in human and canine oncology. The aim of this retrospective study was to explore the prognostic impact on LR and overall survival time (OST) of pretreatment neutrophil-to-lymphocyte ratio (NLR), white blood cell count (WBCC), neutrophil count (NC) and lymphocyte count (LC) in cats with surgically excised FISS. Eighty-two cats with histologically confirmed FISS at first presentation, without distant metastases, and with available pretreatment haematological analyses were retrospectively enrolled. The correlation of NLR, WBCC, NC, LC with tumour variables and patient variables was explored. NLR was correlated with tumour size (P = .004), histological pattern of tumour growth (P = .024) and histotype (P = .029), while WBCC and NC were associated with ulceration (P = .007, P = .011) and pattern of growth (P = .028, P = .004). No significant relationships emerged between LC and any of the considered variables. The impact of NLR, WBCC, NC, LC on LR and OST was then estimated in univariate and multivariate analysis. In univariate analysis, NLR, WBCC and NC were significant prognostic factors for both LR and OST. NLR, WBCC and NC remained prognostic in multivariate analysis for LR but not for OST. When NLR, WBCC and NC were jointly analysed, WBCC was the marker with the greater impact on LR. Preoperative NLR, WBCC and NC may aid in identifying cats at higher risk of LR.
Subject(s)
Cat Diseases/blood , Neoplasm Recurrence, Local/veterinary , Sarcoma/veterinary , Animals , Cat Diseases/surgery , Cats , Female , Injection Site Reaction/veterinary , Leukocyte Count/veterinary , Lymphocyte Count/veterinary , Male , Neoplasm Recurrence, Local/blood , Neoplasm Recurrence, Local/surgery , Neutrophils , Prognosis , Retrospective Studies , Sarcoma/blood , Sarcoma/surgeryABSTRACT
PURPOSE: To develop and validate an Artificial Intelligence (AI) model based on texture analysis of high-resolution T2 weighted MR images able 1) to predict pathologic Complete Response (CR) and 2) to identify non-responders (NR) among patients with locally-advanced rectal cancer (LARC) after receiving neoadjuvant chemoradiotherapy (CRT). METHOD: Fifty-five consecutive patients with LARC were retrospectively enrolled in this study. Patients underwent 3 T Magnetic Resonance Imaging (MRI) acquiring T2-weighted images before, during and after CRT. All patients underwent complete surgical resection and histopathology was the gold standard. Textural features were automatically extracted using an open-source software. A sub-set of statistically significant textural features was selected and two AI models were built by training a Random Forest (RF) classifier on 28 patients (training cohort). Model performances were estimated on 27 patients (validation cohort) using a ROC curve and a decision curve analysis. RESULTS: Sixteen of 55 patients achieved CR. The AI model for CR classification showed good discrimination power with mean area under the receiver operating curve (AUC) of 0.86 (95% CI: 0.70, 0.94) in the validation cohort. The discriminatory power for the NR classification showed a mean AUC of 0.83 (95% CI: 0.71,0.92). Decision curve analysis confirmed higher net patient benefit when using AI models compared to standard-of-care. CONCLUSIONS: AI models based on textural features of MR images of patients with LARC may help to identify patients who will show CR at the end of treatment and those who will not respond to therapy (NR) at an early stage of the treatment.
Subject(s)
Artificial Intelligence , Chemoradiotherapy, Adjuvant/methods , Magnetic Resonance Imaging/methods , Neoadjuvant Therapy/methods , Rectal Neoplasms/diagnostic imaging , Rectal Neoplasms/therapy , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Male , Middle Aged , Prospective Studies , ROC Curve , Rectal Neoplasms/pathology , Rectum/diagnostic imaging , Rectum/pathology , Reproducibility of Results , Retrospective Studies , Treatment OutcomeABSTRACT
Arrhythmic sudden cardiac death (SCD) represents a major worldwide public health problem accounting for 15-20% of deaths. Risk stratification to identify patients at risk of SCD is crucial in order to implement preventive measures in the general population. Several biomarkers have been tested exploring different pathophysiological mechanisms of cardiac conditions. Conflicting results have been described limiting so far their use in clinical practice. The use of new biomarkers such as microRNAs and sex hormones and the emerging role of genetic on risk prediction of SCD is a current research topic showing promising results.This review outlines the role of plasma biomarkers to predict ventricular arrhythmias and SCD in non coronary artery disease with a special focus on their relationship with the genetic biomarkers.
Subject(s)
Arrhythmias, Cardiac/etiology , Death, Sudden, Cardiac/etiology , Genetic Markers , Arrhythmias, Cardiac/blood , Arrhythmias, Cardiac/genetics , Arrhythmias, Cardiac/mortality , Fatty Acids/blood , Genetic Predisposition to Disease , Gonadal Steroid Hormones/blood , Humans , Inflammation Mediators/blood , MicroRNAs/genetics , Molecular Diagnostic Techniques , NAV1.5 Voltage-Gated Sodium Channel/genetics , Natriuretic Peptide, Brain/blood , Phenotype , Predictive Value of Tests , Risk FactorsABSTRACT
Several elicitors, stimulating induced resistance mechanisms, have potential in preventing or mitigating pathogen infections. Some of these compounds, triggering the production of jasmonic acid (JA), a precursor of herbivore-induced plant volatiles, could also play a central role in indirect resistance to pest species, by improving beneficial arthropod performance, and necrotrophic pathogens. In the current work, Trichoderma gamsii/T. asperellum and silica gel treatments - alone and in combination - were studied to evaluate the plant defence mechanism on grapevines (Vitis vinifera L.) by laboratory and field trials. JA production level was measured before and after Plasmopara viticola infection on potted vines. JA production induced by silica gel was higher than that caused by Trichoderma before infection. In Trichoderma-treated plants, JA production increased after P. viticola inoculation. In vineyard field trials, Mymaridae (Hymenoptera: Chalcidoidea) showed higher captures in transparent sticky traps on silica gel-treated plants, in comparison with control. On the other hand, no significant attraction was detected for Ichneumonoidea and other Chalcidoidea in silica gel and T. gamsii/T. asperellum-treated plants. The potential effects of elicitors are discussed, in the frame of attract and reward strategy.
Subject(s)
Plant Diseases/microbiology , Silica Gel , Trichoderma/physiology , Vitis/microbiology , Animals , Cyclopentanes/metabolism , Disease Resistance , Oomycetes/physiology , Oxylipins/metabolism , Plant Diseases/parasitology , Vitis/metabolism , Wasps/physiologyABSTRACT
In this review article we discuss some of the key aspects concerning the development of a polymer-based nanoparticle formulation for intravenous drug delivery. Since numerous preparations fail before and during clinical trials, our aim is to emphasize the main issues that a nanocarrier has to face once injected into the body. These include biocompatibility and toxicity, drug loading and release, nanoparticle storage and stability, biodistribution, selectivity towards the target organs or tissues, internalization in cells and biodegradability. They represent the main checkpoints to define a polymer-based formulation as safe and effective. Indeed, this review is intended to provide guidelines to be followed in the early development of a new nanotherapeutic to hopefully increase the success rate of polymer-based formulations entering clinical trials. The corresponding requirements and characteristics are discussed in the context of some relevant case studies taken from the literature and mainly related to the delivery of lipophilic anticancer therapeutics.
Subject(s)
Antineoplastic Agents , Drug Carriers , Nanoparticles , Neoplasms/drug therapy , Polymers , Administration, Intravenous , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/therapeutic use , Drug Carriers/chemical synthesis , Drug Carriers/chemistry , Drug Carriers/therapeutic use , Humans , Nanoparticles/chemistry , Nanoparticles/therapeutic use , Neoplasms/metabolism , Neoplasms/pathology , Polymers/chemical synthesis , Polymers/chemistry , Polymers/therapeutic useABSTRACT
Metastasis to regional lymph nodes (RLNs) in dogs with cutaneous mast cell tumour (cMCT) has been correlated with shortened survival time and higher risk of spread to distant sites. In the present study, extirpation of non-palpable or normal-sized RLNs was included in the surgical management of cMCT in dogs. Correlations between histological nodal status (HN0-3) and tumour variables were analysed. Ninety-three dogs with single cMCT without distant metastasis that underwent wide surgical excision of the primary tumour and extirpation of non-palpable or normal-sized RLN were included. The association between HN (HN0 vs HN > 0; HN0-1 vs HN2-3) and tumour variables (site, longest diameter, ulceration, 3-tier and 2-tier histological grades) was analysed by a generalized linear model with multinomial error. Then, 33 (35.5%) RLNs were HN0, 14 (15%) were HN1, 26 (28%) were HN2 and 20 (21.5%) were HN3. The presence of positive (HN > 0) RLN was significantly associated with cMCT larger than 3 cm. No other association was statistically significant. Non-palpable/normal-sized RLN in dogs with cMCT can harbour histologically detectable metastatic disease in nearly half of the cases. Extirpation of the RLN should always perfomed to obtain a correct staging of the disease, even in the absence of clinical suspicion of metastasis. Further studies should evaluate the possible therapeutical effect of the tumour burden reduction obtained by exrtipartion of a positive RLN.
Subject(s)
Dog Diseases/pathology , Lymph Node Excision/veterinary , Mastocytosis, Cutaneous/veterinary , Animals , Dog Diseases/diagnosis , Dog Diseases/surgery , Dogs , Female , Lymph Nodes/pathology , Lymphatic Metastasis/pathology , Male , Mastocytosis, Cutaneous/diagnosis , Mastocytosis, Cutaneous/pathology , Mastocytosis, Cutaneous/surgery , Neoplasm Staging/veterinary , Retrospective StudiesABSTRACT
In the original version of this Article, the data accession https://doi.org/10.17882/42182 was omitted from the Data Availability statement.In the first paragraph of the Methods subsection entitled 'Float data processing', the WET Labs ECO-triplet fluorometer was incorrectly referred to as 'WETLabs ECO PUK'. In the final paragraph of this subsection, the WET Labs ECO-series fluorometer was incorrectly referred to as 'WETLabs 413 ECO-series'.In the Methods subsection 'Float estimates of phytoplankton carbon biomass', the average particulate organic carbon-bbp ratio of 37,537 mgC m-2 was incorrectly given as 37,357 mgC m-2.In the second paragraph of the Methods subsection 'Float estimates of population division rates', the symbol for Celsius (C) was omitted from the phrase 'a 10°C increase in temperature'.These errors have now been corrected in the PDF and HTML versions of the Article.
ABSTRACT
Ivabradine, a heart rate reducing agent, protects the vascular system by unidentified mechanisms. We sought to determine the effects of the treatment with ivabradine, started before plaque formation, on early transcriptional changes and endothelium lesions in regions of aorta subjected to disturbed blood flow. Six week-old apolipoprotein E-deficient (ApoE-/-) mice, fed a low-fat diet, were treated with ivabradine to determine the effect on transcriptional changes (2-and 4-week treatment) and on lesions formation (19-week treatment) in the endothelium of the aortic arch. Microarrays analysis (60k probes) of endothelium-enriched RNA was carried out to detect changes in gene expression induced by treatment. Endothelium damage was assessed by en-face immunofluorescence staining for vascular endothelial (VE) cadherin. According to microarray analysis, 930 transcripts were affected by the treatment. We found downregulation of pro-apoptotic and pro-inflammatory genes, the majority of which are nuclear factor-κB (NF-κB)-and/or angiotensin II-regulated genes, and upregulation of anti-inflammatory genes. Many shear stress-responsive genes were affected by the treatment and the MAPK, Notch signalling and sterol metabolic processes were among the most significantly affected pathways. Consistently, we observed increased levels of Hes5, a Notch target gene, together with a reduction of endothelium damage, in the lower aortic arch of treated- compared with untreated- mice. We concluded that an early treatment with ivabradine protected the endothelium of the aortic arch of ApoE-/- mice. Activation of the Notch signalling could be part of the mechanism underlying this protection.
Subject(s)
Atherosclerosis/genetics , Benzazepines/pharmacology , Cardiovascular Agents/pharmacology , Endothelium, Vascular/drug effects , Heart Rate/drug effects , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/metabolism , Aorta, Thoracic/pathology , Apolipoproteins E/genetics , Atherosclerosis/drug therapy , Atherosclerosis/physiopathology , Benzazepines/therapeutic use , Cardiovascular Agents/therapeutic use , Endothelium, Vascular/metabolism , Gene Expression Regulation/drug effects , Gene Ontology , Ivabradine , Mice, Inbred C57BL , Mice, Knockout , Receptors, Notch/metabolism , Transcriptome/drug effectsABSTRACT
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
ABSTRACT
The North Atlantic bloom corresponds to a strong seasonal increase in phytoplankton that produces organic carbon through photosynthesis. It is still debated what physical and biological conditions trigger the bloom, because comprehensive time series of the vertical distribution of phytoplankton biomass are lacking. Vertical profiles from nine floats that sampled the waters of the North Atlantic every few days for a couple of years reveal that phytoplankton populations start growing in early winter at very weak rates. A proper bloom with rapidly accelerating population growth rates instead starts only in spring when atmospheric cooling subsides and the mixed layer rapidly shoals. While the weak accumulation of phytoplankton in winter is crucial to maintaining a viable population, the spring bloom dominates the overall seasonal production of organic carbon.
Subject(s)
Biosensing Techniques/instrumentation , Environmental Monitoring/methods , Eutrophication/physiology , Photosynthesis/physiology , Phytoplankton/physiology , Atlantic Ocean , Biomass , Chlorophyll/physiology , Environmental Monitoring/instrumentation , Seasons , Seawater , TemperatureABSTRACT
The aim of this review is to present the methodologies currently applied to identify microbiota and pathogens transmitted to humans through seafood consumption, focusing on molecular techniques and pointing out their importance, advantages, disadvantages and applicability. Knowledge of available techniques allows researchers to identify which technique best fits their expectations. With such discernment, it will be possible to infer which disadvantages will be present and, therefore, not interfering with the final result. Two methodologies can be employed for this purpose, dependent and independent cultures. However, the dependent culture has certain limitations that can be solved through the independent cultivation techniques, such as PCR, PFGE and NGS, especially through the sequencing of the 16S rRNA region, providing a complete view of microbial diversity. These have revolutionized microbiological knowledge, mainly because they allow for the identification of uncultivable micro-organisms, which represent a substantial portion of total micro-organisms, making it possible to elucidate not yet described taxa which may display pathogenic potential, besides quantifying microbial communities, microbiota genetics, translated proteins and produced metabolites. In addition, transcriptomic and metabolomic techniques also allow for the evaluation of possible impacts that microbial communities may create in their environment, as well as the determination of potential pathogenicity to humans.
Subject(s)
Bacteria/isolation & purification , Microbiota , Polymerase Chain Reaction/methods , Seafood/microbiology , Sequence Analysis, DNA/methods , Bacteria/classification , Bacteria/genetics , Foodborne Diseases/microbiology , HumansABSTRACT
BACKGROUND: Distant metastases in dogs with cutaneous mast cell tumors (cMCT) are rare and incurable. The aims of this prospective study were to clarify the clinico-pathological features of stage IV cMCTs and to identify possible prognostic factors for progression-free interval (PFI) and survival time (ST). MATERIAL AND METHODS: Dogs were eligible for recruitment if they had a previously untreated, histologically confirmed cMCT and if they underwent complete staging demonstrating stage IV disease. Dogs were uniformly followed-up, whereas treatment was not standardized and included no therapy, surgery, radiation therapy, chemotherapy, tyrosine-kinase inhibitors or a combination of these. RESULTS: 45 dogs with stage IV cMCT were enrolled. All dogs had distant metastatic disease, and 41 (91.1%) dogs had also metastasis in the regional lymph node. Histopathological grade and mutational status greatly varied among dogs. Median ST was 110 days. Notably, PFI and ST were independent of well-known prognostic factors, including anatomic site, histological grade, and mutational status. Conversely, tumor diameter >3 cm, more than 2 metastatic sites, bone marrow infiltration, and lack of tumor control at the primary site were confirmed to be negative prognostic factors by multivariate analysis. CONCLUSION: Currently, there is no satisfactory treatment for stage IV cMCT. Asymptomatic dogs with tumor diameter <3 cm and a low tumor burden, without bone marrow infiltration may be candidates for multimodal treatment. Stage IV dogs without lymph node metastasis may enjoy a surprisingly prolonged survival. The achievement of local tumor control seems to predict a better outcome in dogs with stage IV cMCT.
Subject(s)
Dog Diseases/diagnosis , Mastocytosis, Cutaneous/veterinary , Animals , Dog Diseases/pathology , Dog Diseases/therapy , Dogs , Female , Male , Mastocytosis, Cutaneous/diagnosis , Mastocytosis, Cutaneous/pathology , Mastocytosis, Cutaneous/therapy , Prognosis , Prospective StudiesABSTRACT
A 17-month-old female doberman pinscher was referred for an abdominal mass and ascites. Exploratory laparotomy revealed the presence of a large neoplastic mass replacing the right ovary and associated with multiple mesovarian, mesometrial and peritoneal nodules. An ovariohysterectomy was performed. Grossly, the tumour was soft and multilocular with large areas of haemorrhage and necrosis. Microscopically, it was infiltrative and composed of round and polygonal cells arranged respectively in solid sheets or forming distorted tubular structures separated by thick fibrovascular septae. Tubules contained necrotic debris, proteinaceous fluid or small endoluminal papillary structures. Marked cellular atypia, multiple neoplastic emboli and high mitotic count were observed. Immunohistochemically, the round cells uniformly expressed placental alkaline phosphatase, while the polygonal cells arranged in tubules and papillae expressed cytokeratin (CK) AE1/AE3 and CK7. A final diagnosis of metastasizing ovarian embryonal carcinoma (EC), a primitive germ cell tumour characterized by rudimentary epithelial differentiation was made. Canine ovarian EC should be considered as a differential diagnosis for undifferentiated aggressive ovarian tumours in young dogs.